Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events within subject clinical trials introduction new methods statistical models
… He has over 10 years of experience as a statistician within consulting environment. Mr. Le Moine is experienced in … of a variety of studies, including health economics, clinical trials and real-world evidence. Specifically, Mr. Le Moine …
… reviews. RTI-HS has been working with Nested Knowledge’s new Gen-AI tools for its complex data extraction and design … analytical and technical capabilities focused on specific clinical inquiries or outcomes. “We see RTI as a perfect … maintains a legacy of setting scientific standards within the industry and employs the right approaches and …
… working as a statistician for research foundations and clinical research organizations. Before joining RTI-HS, she … research organization as a statistician in clinical trials and observational studies, managing all statistical aspects for the design and analysis. She also …
… to slow kidney function decline in various short-term clinical studies. They wanted to assess their treatment … in kidney function over a longer period, using existing clinical trial data. THE CHALLENGE Our client had data from … randomization. The team employed piecewise mixed models to account for treatment gaps. …
… during loncastuximab tesirine treatment in a phase 2 clinical trial (LOTIS-2). Spira A, Zhou X, Liao L, Yu E, Chen …
… diffuse Large b-cell lymphoma treated in a phase 2 clinical trial (LOTIS-2). Poster …
… She has over 20 years of experience as a statistician within consulting, regulatory, and academic environments. Ms. … meta-analysis, epidemiology, health economics, and clinical trials. Prior to joining RTI-HS, Ms. Hawe was Head of …
… diffuse large B-cell lymphoma treated in a phase 2 clinical trial (LOTIS 2). Spira A, Liao L, Zhou X, …
… hopes juxtaposed with the dashing heartbreak of failed trials. As the key to unlocking a cure continues to elude … are designed to meet the needs of patients and the clinical trials are conducted to demonstrate not only clinical outcomes, but also the importance of those outcomes …
… evaluate evidence from patient-reported outcomes (PROs) in clinical trials. Study sponsors pursuing PRO drug labeling … face when including PRO-related endpoints in cancer clinical research? And how can these challenges be overcome? …